CCL5 and infection: The effect of the combination of CCL5 5p12 5m-C37 with the CCR5 antagonist MVC and, separately, with TDF (a nucleotide analogue reverse transcriptase inhibitor) was investigated in acute infection inhibition experiments (Figure 4A,B).